Cargando…
Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices
Severe combined immunodeficiency (SCID) includes a group of monogenic disorders presenting with severe T cell lymphopenia (TCL) and high mortality, if untreated. The newborn screen (NBS) for SCID, included in the recommended universal screening panel (RUSP), has been widely adopted across the US and...
Autores principales: | Knight, Vijaya, Heimall, Jennifer R., Wright, Nicola, Dutmer, Cullen M., Boyce, Thomas G., Torgerson, Troy R., Abraham, Roshini S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569936/ https://www.ncbi.nlm.nih.gov/pubmed/33239578 http://dx.doi.org/10.3390/ijns6030052 |
Ejemplares similares
-
Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019) -
Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018) -
Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India
por: Aluri, Jahnavi, et al.
Publicado: (2019) -
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)
por: Speckmann, Carsten, et al.
Publicado: (2023) -
Establishing Newborn Screening for SCID in the USA; Experience in California †
por: Puck, Jennifer M., et al.
Publicado: (2021)